Check out your Company Bowl for anonymous work chats.
To mark 25 years of doing business in Ireland, Waters announced an expansion of a new Clinical R&D Center at our Wexford facility with Irish government officials and business leaders in attendance. The €6 million investment will fund research and development of new clinical diagnostics products. Waters’ Wexford facility is our primary site for manufacturing and delivery of in-vitro diagnostic (IVD) systems, reagent kits, and software used by thousands of hospitals and laboratories worldwide for applications that include health screening for millions of newborn babies. Click below to learn more:
Welcome to Wilmslow, United Kingdom! Our mass spectrometry center of excellence is located in northern England, minutes from the city center of Manchester. It’s home to nearly 700 employees, 300 instrument bays, and an expanding manufacturing capacity. Click the video below for a site tour!
We are proud to announce the U.S. Green Building Council has designated Waters as the first and only LEED certified chemical manufacturing facility in Massachusetts and among a small number in the U.S. Our new 140,000 square-foot facility is designed to help Waters significantly reduce energy consumption, decrease water use by 20% and cut industrial waste volume by 50% at this location. Read more about the significant impact below:
Waters Student Academy provides underrepresented students with STEM education, exposure, and experience to ensure that the scientific community is more representative of the society we live in. The WSA Class of 2022 spent five weeks at Waters and taught us so much. To hear from the students and learn more about this annual program, click on the link below.
"A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to 'solve the problems that matter.'” Congratulations to our CEO, Dr. Udit Batra who has been honored as a 2022 Red Jacket recipient! Click on the link below to read the full PharmaVoice article.
Newborn screening labs worldwide trust Waters' OMNI-Lab NBS Laboratory Information Management System (LIMS) to manage samples and test data from millions of babies every year. Newborn screening identifies babies who are at risk of having more than 35 potentially life-threatening disorders before they ever get sick to get them treatment as soon as possible. To learn more about the OMNI-Lab NBS LIMS, click on the link below.
Waters second quarter 2022 financial results demonstrate continued momentum with broad-based strength across our end-markets and geographies. Watch to learn more:
We are thrilled to share that Forbes ranked Waters number 12 on their list of Best Employers in Massachusetts! Beating out our Bay State competitors, we are the only life sciences tools company to make the 2022 Best-in-State Employers List for Massachusetts. Click on the link below to learn more.
Our Milford, MA location offers many amenities and new opportunities!
In honor of International Women’s Day, our colleagues around the world share how they break the bias each and every day.
